New Insights into the Androgen-Targeted Therapies and Epigenetic Therapies in Prostate Cancer

Figure 1

Schematic representation of the structure of human androgen receptor NTD: N-terminal domain, DBD: DNA-binding domain, LBD: ligand-binding domain, CTE: C-terminal extension, CTD: C-terminal domain, AF-1: activation function-1, AF-2: activation function-2.